Kyverna Therapeutics Names Greg Martini as Chief Financial Officer
Go back to Kyverna Therapeutics Names Greg Martini as Chief Financial Officer| (NASDAQ: KYTX) | Delayed: 6.39 +0.21 (3.40%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.18 | 52 Week High | $ | |||
| Open | $6.20 | 52 Week Low | $ | |||
| Day High | $6.58 | P/E | N/A | |||
| Day Low | $6.18 | EPS | $ | |||
| Volume | 876,450 | |||||



